BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2114511)

  • 1. Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent.
    Young SW; Bradley B; Muller HH; Rubin DL
    Magn Reson Imaging; 1990; 8(3):267-76. PubMed ID: 2114511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
    Young SW; Simpson BB; Ratner AV; Matkin C; Carter EA
    Magn Reson Med; 1989 Apr; 10(1):1-13. PubMed ID: 2502699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
    Ni Y; Marchal G; Zhang X; Van Hecke P; Michiels J; Yu J; Rummeny E; Lodemann KP; Baert AL
    Invest Radiol; 1993 Jun; 28(6):520-8. PubMed ID: 8320070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images.
    Vogl TJ; Hamm B; Schnell B; McMahon C; Branding G; Lissner J; Wolf KJ
    J Magn Reson Imaging; 1993; 3(1):51-8. PubMed ID: 8381314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP.
    Gallez B; Bacic G; Swartz HM
    Magn Reson Med; 1996 Jan; 35(1):14-9. PubMed ID: 8771018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic enhancement after low-dose infusion of Mn-DPDP.
    Gehl HB; Vorwerk D; Klose KC; Günther RW
    Radiology; 1991 Aug; 180(2):337-9. PubMed ID: 1906189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
    Vogl TJ; Hamm B; Schnell B; Eibl-Eibesfeldt B; Steiner S; Lissner J
    Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction.
    Ni Y; Petré C; Lukito G; Marchal G; Grant D; Gray TJ; Baert AL
    Acad Radiol; 1995 Apr; 2(4):300-5. PubMed ID: 9419566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mn-DPDP enhanced MRI in experimental bile duct obstruction.
    Marchal G; Ni Y; Zhang X; Yu J; Lodemann KP; Baert AL
    J Comput Assist Tomogr; 1993; 17(2):290-6. PubMed ID: 8454757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings.
    Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW
    Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
    Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
    Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM; Earls JP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
    Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
    Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
    Slater GJ; Saini S; Mayo-smith WW; Sharma P; Eisenberg PJ; Hahn PF
    Clin Radiol; 1996 Jul; 51(7):484-6. PubMed ID: 8689823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic contrast enhancement with Mn-bis pyridoxal ethylene diamine diacetic acid and the influence of a hormonal stimulation of the pancreas in pigs.
    Blume J; Palmié S; Aue B; Spielmann RP; Sievers E; Lodemann KP; Heller M
    Acad Radiol; 1994 Nov; 1(3):253-60. PubMed ID: 9419495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation].
    Dobritz M; Fellner FA; Baum U; Nömayr A; Lell M; Klein P; Papadopoulos T; Bautz W
    Rofo; 2002 Jul; 174(7):893-7. PubMed ID: 12101481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
    Ni Y; Marchal G; Yu J; Rummeny E; Zhang X; Lodemann KP; Baert AL
    Radiology; 1993 Jul; 188(1):45-51. PubMed ID: 8390071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine.
    Gallez B; Baudelet C; Adline J; Charbon V; Lambert DM
    Magn Reson Imaging; 1996; 14(10):1191-5. PubMed ID: 9065910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging assessment of experimental hepatic dysfunction with Mn-DPDP.
    Coley BD; Mattrey RF; Baker KG; Peterson T; Burgan AR
    J Magn Reson Imaging; 1995; 5(1):11-6. PubMed ID: 7696800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.